Filed: 5/15/2024ACC: 0001591986-24-000005
📋 What this filing means
AQUILO CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $133.42M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$133.42M
Total AUM (reported)
5.80M
Total Shares
Allocation by class
COM$115.79M86.8%
ADS$12.40M9.3%
COM NEW$5.23M3.9%
Portfolio Concentration
Top 3$62.36M46.7%
4–10$71.06M53.3%
Top 3 weight
46.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 5.80M
Sole
Full voting authority
5.80M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole10
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings10
Rows:
ARROWHEAD PHARMACEUTICALS IN
SOLEShares908.47K
TypeSH
Market value$25.98M
19.47%
Sole
908.47K
Shared
0.00
None
0.00
REGENXBIO INC
SOLEShares906.25K
TypeSH
Market value$19.09M
14.31%
Sole
906.25K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares182.15K
TypeSH
Market value$17.28M
12.95%
Sole
182.15K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares405.77K
TypeSH
Market value$16.75M
12.55%
Sole
405.77K
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares388.74K
TypeSH
Market value$15.63M
11.71%
Sole
388.74K
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares574.21K
TypeSH
Market value$12.40M
9.30%
Sole
574.21K
Shared
0.00
None
0.00
MERUS N V
SOLEShares255.11K
TypeSH
Market value$11.49M
8.61%
Sole
255.11K
Shared
0.00
None
0.00
SUTRO BIOPHARMA INC
SOLEShares1.17M
TypeSH
Market value$6.58M
4.94%
Sole
1.17M
Shared
0.00
None
0.00
PRECISION BIOSCIENCES INC
SOLEShares385.44K
TypeSH
Market value$5.23M
3.92%
Sole
385.44K
Shared
0.00
None
0.00
REPARE THERAPEUTICS INC
SOLEShares633.27K
TypeSH
Market value$2.98M
2.24%
Sole
633.27K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARROWHEAD PHARMACEUTICALS INSOLE | COM | 908.47K | SH | $25.98M 19.47% | 908.47K | 0.00 | 0.00 |
REGENXBIO INCSOLE | COM | 906.25K | SH | $19.09M 14.31% | 906.25K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 182.15K | SH | $17.28M 12.95% | 182.15K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 405.77K | SH | $16.75M 12.55% | 405.77K | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 388.74K | SH | $15.63M 11.71% | 388.74K | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADS | 574.21K | SH | $12.40M 9.30% | 574.21K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 255.11K | SH | $11.49M 8.61% | 255.11K | 0.00 | 0.00 |
SUTRO BIOPHARMA INCSOLE | COM | 1.17M | SH | $6.58M 4.94% | 1.17M | 0.00 | 0.00 |
PRECISION BIOSCIENCES INCSOLE | COM NEW | 385.44K | SH | $5.23M 3.92% | 385.44K | 0.00 | 0.00 |
REPARE THERAPEUTICS INCSOLE | COM | 633.27K | SH | $2.98M 2.24% | 633.27K | 0.00 | 0.00 |